This figure corresponds to the Average Price over the previous 50/200 days.
For Biogen stocks, the 50-day moving average is the resistance level today.
For Biogen stocks, the 200-day moving average is the resistance level today.
Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Biogen
stock price in 2024, 2025, 2026, 2027, 2028.
How much will one Biogen share be worth in
2024 - 2028?
When should I take profit in Biogen stock?
When should I record a loss on Biogen stock?
What are analysts' forecasts for Biogen stock?
What is the future of Biogen stock?
We forecast Biogen stock performance using neural networks based on historical data on Biogen stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Biogen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2024, 2025, 2026, 2027 and 2028)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biogen shares. This happens once a day.
Historical and forecast chart of Biogen stock
The chart below shows the historical price of Biogen stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Biogen stock price can be found in the table below.
Long-term forecasts by years.
Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.
The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.
Forecast target price for 12-08-2023: $225.38. Negative dynamics for Biogen shares will prevail with possible volatility of 3.926%. Pessimistic target level: 220.04 Optimistic target level: 229.04
Biogen Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $224.37. Negative dynamics for Biogen shares will prevail with possible volatility of 3.001%. Pessimistic target level: 221.95 Optimistic target level: 228.81
Biogen Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $217.64. Negative dynamics for Biogen shares will prevail with possible volatility of 2.714%. Pessimistic target level: 213.00 Optimistic target level: 218.95
Biogen Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $216.40. Negative dynamics for Biogen shares will prevail with possible volatility of 3.204%. Pessimistic target level: 213.80 Optimistic target level: 220.88
Biogen Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $221.92. Positive dynamics for Biogen shares will prevail with possible volatility of 2.278%. Pessimistic target level: 219.92 Optimistic target level: 225.05
Biogen Stock Forecast 12-13-2023.
Forecast target price for 12-13-2023: $225.05. Positive dynamics for Biogen shares will prevail with possible volatility of 3.407%. Pessimistic target level: 220.12 Optimistic target level: 227.88
Market capitalization of the Biogen Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of BIIB shares in the company outstanding by the market price of one share.
EBITDA:
2 536 600 000 $
EBITDA of Biogen is earnings before interest, income tax and depreciation of assets.
PE Ratio:
23.31
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
6.24
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
0.0371
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
9.99
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
-0.438
Quarterly Revenue Growth YOY:
0.009
Trailing PE:
23.31
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
14.31
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
3.946
Enterprise Value (EV) /Revenue
EV To EBITDA:
17.04
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
144898000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website